ACCESS Newswire
17 Nov 2023, 02:49 GMT+10
PLAYA DEL CARMEN, MEXICO / ACCESSWIRE / November 16, 2023 / Ibogaine By David Dardashti, a leading ibogaine treatment center and research facility, has released the results of a new study that measured the bioavailability factors of ibogaine hydrochloride, a psychedelic compound derived from a plant native to West Africa, in a patient with opioid use disorder. The study, which was verified by Harvard psychiatrist Dr. Ashok Barucha, involved a 10-day ibogaine treatment for a 52-year-old male patient who had been using opioids for almost 20 years.
The study found that ibogaine hydrochloride was well absorbed and metabolized by the patient, producing noribogaine, a long-lasting metabolite that stays in the body for several months after treatment and helps with depression, cravings, and physical performance. The study also found that ibogaine treatment improved various health parameters for the patient, such as blood pressure, heart rate, glucose levels, cholesterol levels, liver enzymes, kidney function, and inflammation. The patient reported a cessation of opioid use for three months after the treatment.
Some of the notable improvements observed in the patient's health parameters are as follows:
In conclusion , the blood report demonstrates the effects of a 10-day ibogaine treatment on various health parameters. While some fluctuations were observed, most parameters remained stable or improved, including blood pressure, lipid profile, and kidney function. However, glucose levels and substance use concerns should be closely monitored and addressed as part of ongoing care. Overall, ibogaine treatment appears to have had several positive impacts on the patient's health.
The researchers hope that their study will contribute to the scientific understanding of ibogaine's potential as a novel pharmacotherapy for opioid addiction and encourage further research and regulation of this promising substance.
Readers will find test results in the provided link: https://docs.google.com/document/d/11vwK_GNpuimDx-h37pkcrxqR5cM6VK6H/edit#heading=h.fsaicw69rpei
For more information, please contact:
David Dardashti
Ibogaine By David Dardashti
Email: [email protected]
Phone: +1-800-818-4511
SOURCE: IBOGAINE
Get a daily dose of Albuquerque Express news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Albuquerque Express.
More InformationDHARAMSHALA, India: The Dalai Lama turned 90 on July 6, celebrated by thousands of followers in the Himalayan town of Dharamshala,...
ZAGREB, Croatia: A massive concert by popular Croatian singer Marko Perković, known by his stage name Thompson, has drawn widespread...
WASHINGTON, D.C.: Elon Musk's entry into the political arena is drawing pushback from top U.S. officials and investors, as his decision...
CULVER CITY, California: TikTok is preparing to roll out a separate version of its app for U.S. users, as efforts to secure a sale...
WASHINGTON, D.C.: President Donald Trump claimed he was unaware that the term shylock is regarded as antisemitic when he used it in...
PARIS, France: A strike by French air traffic controllers demanding improved working conditions caused significant disruptions during...
OTTAWA, Canada: With Canada Post struggling to maintain operations amid labour unrest, rivals like FedEx and UPS are stepping in to...
NEW YORK, New York - U.S. and global markets showed a mixed performance in Tuesday's trading session, with some indices edging higher...
PARIS, France: French military and intelligence officials have accused China of orchestrating a covert campaign to damage the reputation...
NEW DELHI, India: Birkenstock is stepping up its efforts to protect its iconic sandals in India, as local legal representatives conducted...
HONG KONG: China has fired back at the European Union in an escalating trade dispute by imposing new restrictions on medical device...
NEW YORK, New York - Monday's trading session saw mixed performances across U.S. and global markets, with several major indices posting...